CKS1B and plasma cell myeloma: In particular, they found that overexpression of CKS1B, a cell cycle regulator, was highly associated with an aggressive clinical course34,35 and was found to promote myeloma cell growth by activating cyclin-dependent kinases and through SKP2-mediated ubiquitination of the tumor suppressor p27Kip1 34,36.